Lupin launches Turqoz (Norgestrel and Ethinyl Estradiol) Tablets in US
Norgestrel and Ethinyl Estradiol Tablets USP (RLD: Lo/Ovral-28) had estimated annual sales of US $33 million in the US
Norgestrel and Ethinyl Estradiol Tablets USP (RLD: Lo/Ovral-28) had estimated annual sales of US $33 million in the US
The product has been in-licensed from Strides and will be commercialized by Amneal
Currently, Venkat is Lead – Market Access, India at Pfizer
The product is expected to be launched in FY25
A new GSK survey shows a large number of adults do not understand how shingles may be triggered
The full transition of Viatris' biosimilars operations to Biocon Biologics in Europe represents another significant milestone
Equipped with most advanced Distributed Control System (DCS) automation technology, the facility has been set up with an investment of Rs. 200 crore
Establishes connected software and data foundation for the future with next-generation life sciences CRM and harmonized customer data
Both the India and GCC entities will be operated by separate dedicated management teams
Almost 300 million people globally have chronic hepatitis B
Subscribe To Our Newsletter & Stay Updated